Takeda sues Mylan over gout generic
05-12-2019
Takeda subsidiary ordered to pay Bayer $182m after overturn bid fails
27-08-2019
Jonathan Weiss / Shutterstock.com
German pharmaceutical company Stada Arzneimittel has acquired a portfolio of products from Takeda for $660 million.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Takeda, generics, Stada, diabetes, generics, acquisitions, supplements, vitamins, blood pressure
